187 related articles for article (PubMed ID: 14615147)
1. Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain.
König P; Beer M; Makoschey B; Teifke JP; Polster U; Giesow K; Keil GM
Vaccine; 2003 Dec; 22(2):202-12. PubMed ID: 14615147
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
[TBL] [Abstract][Full Text] [Related]
4. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
[TBL] [Abstract][Full Text] [Related]
5. A study on latency in calves by five vaccines against bovine herpesvirus-1 infection.
Castrucci G; Frigeri F; Salvatori D; Ferrari M; Dico ML; Rotola A; Sardonini Q; Petrini S; Cassai E
Comp Immunol Microbiol Infect Dis; 2002 Jul; 25(4):205-15. PubMed ID: 12135235
[TBL] [Abstract][Full Text] [Related]
6. Longevity of protective immunity to experimental bovine herpesvirus-1 infection following inoculation with a combination modified-live virus vaccine in beef calves.
Ellis J; Waldner C; Rhodes C; Ricketts V
J Am Vet Med Assoc; 2005 Jul; 227(1):123-8. PubMed ID: 16013547
[TBL] [Abstract][Full Text] [Related]
7. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
Kalthoff D; König P; Trapp S; Beer M
Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
[TBL] [Abstract][Full Text] [Related]
8. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
[TBL] [Abstract][Full Text] [Related]
9. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease.
Mahan SM; Sobecki B; Johnson J; Oien NL; Meinert TR; Verhelle S; Mattern SJ; Bowersock TL; Leyh RD
J Am Vet Med Assoc; 2016 Jun; 248(11):1280-6. PubMed ID: 27172345
[TBL] [Abstract][Full Text] [Related]
11. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host.
Gao Y; Leary TP; Eskra L; Splitter GA
Vaccine; 1994 Feb; 12(2):145-52. PubMed ID: 8147097
[TBL] [Abstract][Full Text] [Related]
12. Protective immunity following vaccination with a recombinant multiple-epitope protein of bovine herpesvirus type I in a rabbit model.
Wen X; Tong X; Wang M; Wang J; Ni H; Ran X
Appl Microbiol Biotechnol; 2020 Apr; 104(7):3011-3023. PubMed ID: 32002602
[TBL] [Abstract][Full Text] [Related]
13. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle.
van Drunen Littel-van den Hurk S; Van Donkersgoed J; Kowalski J; van den Hurk JV; Harland R; Babiuk LA; Zamb TJ
Vaccine; 1994 Nov; 12(14):1295-302. PubMed ID: 7856294
[TBL] [Abstract][Full Text] [Related]
14. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
15. No vaccine interference between bovine coronavirus and bovine herpesvirus-1 in a randomized trial when coadministrating two intranasal modified-live viral vaccines to neonatal calves.
Bolton MW; Nordstrom S; Hill K; Midla L; Rajamanikam K; Griebel PJ
Am J Vet Res; 2024 May; 85(5):. PubMed ID: 38457927
[TBL] [Abstract][Full Text] [Related]
16. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors.
Pontarollo RA; Babiuk LA; Hecker R; van Drunen Littel-van den Hurk S
J Gen Virol; 2002 Dec; 83(Pt 12):2973-2981. PubMed ID: 12466473
[TBL] [Abstract][Full Text] [Related]
18. Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus.
Toussaint JF; Rziha HJ; Bauer B; Letellier C; Kerkhofs P
Vet Rec; 2004 Oct; 155(18):553-8. PubMed ID: 15559987
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1.
Zakhartchouk AN; Pyne C; Mutwiri GK; Papp Z; Baca-Estrada ME; Griebel P; Babiuk LA; Tikoo SK
J Gen Virol; 1999 May; 80 ( Pt 5)():1263-1269. PubMed ID: 10355773
[TBL] [Abstract][Full Text] [Related]
20. Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1.
Khattar SK; Collins PL; Samal SK
Vaccine; 2010 Apr; 28(18):3159-70. PubMed ID: 20189484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
